Industry, regulators hit reset button on product serialization
While California’s e-pedigree initiative sits on a shelf, actions in Washington and Brussels point to renewed efforts for track-and-trace of pharmaceuticals
Patient-centered
Seattle nonprofit’s implementation highlights role of pharmacist in patient care
Study finds addiction vigilance intervention effort effective
Opioid abuse detected by program that may be useful in REMS and post-market surveillance
Independent Pharmacies Promote the Value of Their Patient Contact to the Pharma Industry
Although beset by less-than-friendly federal reimbursement policies, independent pharmacies are maintaining their viability for pharmaceutical delivery
Building an Alternative Distribution Model for Ultra-Orphan Diseases
Biopharmaceutical manufacturers turn to a direct-distribution model to leverage opportunities for cost-effective drug delivery and personalized health management services
CVS Caremark settles with FTC and HHS over patient-privacy issues
Alleged mishandling of discarded patient records call the giant retailer’s privacy safeguards into question
Now 50 years old, Research Triangle Park looks forward
The high-tech mecca plans to maintain its status as an economic driver for North Carolina
Children's hospital underway in Florida
Nemours plans campus for pediatric treatment and research
Entering the Brazilian Pharmaceutical Market
Stable economics and growing healthcare concerns make Brazil one of the top emerging markets, with a current growth rate >20%
The end or just the beginning? Exploring federal preemption of state marketing and distribution laws
Multiplying state laws on marketing and distribution disclosures might be pre-empted by new federal legislation
The Shape of the Electronic Medical Record Market
McKesson is a heavy hitter in the category, says Kalorama Information
Long-Term Drug Approval Trends Highlight the Industry's Productivity Dilemma
Higher complexity—and expense—are the reality for most drug research, says Tufts
Novartis Managed Care Report Finds Higher Barriers to Drug Access
Higher co-pays, ‘NDC block policies’ and multiple tiers add to drug benefit complexity
Wolters Kluwer Scores Prescription-Sales Data Contract From BMS
Dataset has ‘exclusive’ source, the ArcLight consortium
Walgreens Builds out its Healthcare Offerings to Employers With 'Complete Care and Well-Being'
Program combines retail pharmacy, in-store and onsite clinics for employer health plans
Colorcon Opens West Coast Technology Center
Center for Healthcare Supply Chain Research Renews Its Board
HDMA’s educational arm has new chair, vice chair
A REMS Will Be Part of the Expected Launch of Anti-Epilepsy Drug From Ovation Pharmaceuticals
FDA specifies a patient registry and follow-up studies
Overlapping, Imprecise Regulations Cause a Hiccup In Temperature-Sensitive Pharma Shipping
Delta Air backs away from prohibiting battery-powered temperature sensors in temperature-controlled pharma shipping
UPS strikes pioneering supply-chain deal with Merck
Big Brown will take over existing Merck distribution centers, absorbing them into its international healthcare logistics unit; Merck is also selling a lab to PPD
Marching up the channel management curve
Financial and business changes are driving an evolution in channel management strategies
Examining the ROI of personalized medicine
New Deloitte study finds “profound” positive and negative ROIs for combined therapies and diagnostics based on genetics
West adds to its syringe-development capabilities with designer partnership
Collaboration has multiple designs for prefilled and other syringes in the works
No surprise here: FDA drug oversight is now a 'high risk' government operation
FDA’s management of drug and device safety enters GAO’s biennial watch list
New online portal makes bid for industry-physician communications
iMedicor offers physician education, EMR file transfers and community services
Leading in Challenging Times
It has been said that one should never miss an opportunity to make the most of a crisis. The steady stream of headlines announcing staff cuts, delays in drug approvals and a narrowing of R&D focus for pharmaceutical and biotech companies indicate there will be no shortage of opportunities in 2009.
Specialty Pharmaceuticals and the Emergence of Sub-Specialty Pharmacy
‘Ultra-orphan’ diseases will alter the specialty distribution process
Developing a comprehensive pre-launch trade and distribution strategy for specialty products
Establishing appropriate trade channels is crucial to the launch success of specialty pharmaceuticals
Functional labels enhance patient safety and boost market access
Functional (“peel-off”) labels, common in Europe for injectables, represent a significant packaging improvement for safer and more efficient drug administration
Rethinking Sample Distribution
As the number of specific services associated with sample distribution has grown, so has the number of service providers a manufacturer might use. It’s time to think about consolidating these services